Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmaceutical CDMO Services Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Drug Substance Development and Manufacturing
1.2.3 Specialized Services
1.2.4 Lab-based Services
1.3 Market by Application
1.3.1 Global Pharmaceutical CDMO Services Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Innovative Medicine
1.3.3 Patented Drug
1.3.4 Patent Expired Drug
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pharmaceutical CDMO Services Market Perspective (2018-2033)
2.2 Pharmaceutical CDMO Services Growth Trends by Region
2.2.1 Global Pharmaceutical CDMO Services Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Pharmaceutical CDMO Services Historic Market Size by Region (2018-2023)
2.2.3 Pharmaceutical CDMO Services Forecasted Market Size by Region (2024-2033)
2.3 Pharmaceutical CDMO Services Market Dynamics
2.3.1 Pharmaceutical CDMO Services Industry Trends
2.3.2 Pharmaceutical CDMO Services Market Drivers
2.3.3 Pharmaceutical CDMO Services Market Challenges
2.3.4 Pharmaceutical CDMO Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharmaceutical CDMO Services Players by Revenue
3.1.1 Global Top Pharmaceutical CDMO Services Players by Revenue (2018-2023)
3.1.2 Global Pharmaceutical CDMO Services Revenue Market Share by Players (2018-2023)
3.2 Global Pharmaceutical CDMO Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pharmaceutical CDMO Services Revenue
3.4 Global Pharmaceutical CDMO Services Market Concentration Ratio
3.4.1 Global Pharmaceutical CDMO Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical CDMO Services Revenue in 2022
3.5 Pharmaceutical CDMO Services Key Players Head office and Area Served
3.6 Key Players Pharmaceutical CDMO Services Product Solution and Service
3.7 Date of Enter into Pharmaceutical CDMO Services Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmaceutical CDMO Services Breakdown Data by Type
4.1 Global Pharmaceutical CDMO Services Historic Market Size by Type (2018-2023)
4.2 Global Pharmaceutical CDMO Services Forecasted Market Size by Type (2024-2033)
5 Pharmaceutical CDMO Services Breakdown Data by Application
5.1 Global Pharmaceutical CDMO Services Historic Market Size by Application (2018-2023)
5.2 Global Pharmaceutical CDMO Services Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Pharmaceutical CDMO Services Market Size (2018-2033)
6.2 North America Pharmaceutical CDMO Services Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Pharmaceutical CDMO Services Market Size by Country (2018-2023)
6.4 North America Pharmaceutical CDMO Services Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pharmaceutical CDMO Services Market Size (2018-2033)
7.2 Europe Pharmaceutical CDMO Services Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Pharmaceutical CDMO Services Market Size by Country (2018-2023)
7.4 Europe Pharmaceutical CDMO Services Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pharmaceutical CDMO Services Market Size (2018-2033)
8.2 Asia-Pacific Pharmaceutical CDMO Services Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Pharmaceutical CDMO Services Market Size by Region (2018-2023)
8.4 Asia-Pacific Pharmaceutical CDMO Services Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pharmaceutical CDMO Services Market Size (2018-2033)
9.2 Latin America Pharmaceutical CDMO Services Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Pharmaceutical CDMO Services Market Size by Country (2018-2023)
9.4 Latin America Pharmaceutical CDMO Services Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharmaceutical CDMO Services Market Size (2018-2033)
10.2 Middle East & Africa Pharmaceutical CDMO Services Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Pharmaceutical CDMO Services Market Size by Country (2018-2023)
10.4 Middle East & Africa Pharmaceutical CDMO Services Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Recipharm AB
11.1.1 Recipharm AB Company Detail
11.1.2 Recipharm AB Business Overview
11.1.3 Recipharm AB Pharmaceutical CDMO Services Introduction
11.1.4 Recipharm AB Revenue in Pharmaceutical CDMO Services Business (2018-2023)
11.1.5 Recipharm AB Recent Development
11.2 AMRI Global
11.2.1 AMRI Global Company Detail
11.2.2 AMRI Global Business Overview
11.2.3 AMRI Global Pharmaceutical CDMO Services Introduction
11.2.4 AMRI Global Revenue in Pharmaceutical CDMO Services Business (2018-2023)
11.2.5 AMRI Global Recent Development
11.3 Patheon N.V.
11.3.1 Patheon N.V. Company Detail
11.3.2 Patheon N.V. Business Overview
11.3.3 Patheon N.V. Pharmaceutical CDMO Services Introduction
11.3.4 Patheon N.V. Revenue in Pharmaceutical CDMO Services Business (2018-2023)
11.3.5 Patheon N.V. Recent Development
11.4 Aenova Group
11.4.1 Aenova Group Company Detail
11.4.2 Aenova Group Business Overview
11.4.3 Aenova Group Pharmaceutical CDMO Services Introduction
11.4.4 Aenova Group Revenue in Pharmaceutical CDMO Services Business (2018-2023)
11.4.5 Aenova Group Recent Development
11.5 Catalent, Inc.
11.5.1 Catalent, Inc. Company Detail
11.5.2 Catalent, Inc. Business Overview
11.5.3 Catalent, Inc. Pharmaceutical CDMO Services Introduction
11.5.4 Catalent, Inc. Revenue in Pharmaceutical CDMO Services Business (2018-2023)
11.5.5 Catalent, Inc. Recent Development
11.6 Amatsigroup
11.6.1 Amatsigroup Company Detail
11.6.2 Amatsigroup Business Overview
11.6.3 Amatsigroup Pharmaceutical CDMO Services Introduction
11.6.4 Amatsigroup Revenue in Pharmaceutical CDMO Services Business (2018-2023)
11.6.5 Amatsigroup Recent Development
11.7 WuXi AppTec Group
11.7.1 WuXi AppTec Group Company Detail
11.7.2 WuXi AppTec Group Business Overview
11.7.3 WuXi AppTec Group Pharmaceutical CDMO Services Introduction
11.7.4 WuXi AppTec Group Revenue in Pharmaceutical CDMO Services Business (2018-2023)
11.7.5 WuXi AppTec Group Recent Development
11.8 Strides Pharma Science Limited
11.8.1 Strides Pharma Science Limited Company Detail
11.8.2 Strides Pharma Science Limited Business Overview
11.8.3 Strides Pharma Science Limited Pharmaceutical CDMO Services Introduction
11.8.4 Strides Pharma Science Limited Revenue in Pharmaceutical CDMO Services Business (2018-2023)
11.8.5 Strides Pharma Science Limited Recent Development
11.9 Piramal Pharma Solutions
11.9.1 Piramal Pharma Solutions Company Detail
11.9.2 Piramal Pharma Solutions Business Overview
11.9.3 Piramal Pharma Solutions Pharmaceutical CDMO Services Introduction
11.9.4 Piramal Pharma Solutions Revenue in Pharmaceutical CDMO Services Business (2018-2023)
11.9.5 Piramal Pharma Solutions Recent Development
11.10 Siegfried Ltd
11.10.1 Siegfried Ltd Company Detail
11.10.2 Siegfried Ltd Business Overview
11.10.3 Siegfried Ltd Pharmaceutical CDMO Services Introduction
11.10.4 Siegfried Ltd Revenue in Pharmaceutical CDMO Services Business (2018-2023)
11.10.5 Siegfried Ltd Recent Development
11.11 Fareva Group
11.11.1 Fareva Group Company Detail
11.11.2 Fareva Group Business Overview
11.11.3 Fareva Group Pharmaceutical CDMO Services Introduction
11.11.4 Fareva Group Revenue in Pharmaceutical CDMO Services Business (2018-2023)
11.11.5 Fareva Group Recent Development
11.12 FAMAR Health Care Services
11.12.1 FAMAR Health Care Services Company Detail
11.12.2 FAMAR Health Care Services Business Overview
11.12.3 FAMAR Health Care Services Pharmaceutical CDMO Services Introduction
11.12.4 FAMAR Health Care Services Revenue in Pharmaceutical CDMO Services Business (2018-2023)
11.12.5 FAMAR Health Care Services Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Pharmaceutical CDMO Services Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Drug Substance Development and Manufacturing
Table 3. Key Players of Specialized Services
Table 4. Key Players of Lab-based Services
Table 5. Global Pharmaceutical CDMO Services Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Pharmaceutical CDMO Services Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Pharmaceutical CDMO Services Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Pharmaceutical CDMO Services Market Share by Region (2018-2023)
Table 9. Global Pharmaceutical CDMO Services Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global Pharmaceutical CDMO Services Market Share by Region (2024-2033)
Table 11. Pharmaceutical CDMO Services Market Trends
Table 12. Pharmaceutical CDMO Services Market Drivers
Table 13. Pharmaceutical CDMO Services Market Challenges
Table 14. Pharmaceutical CDMO Services Market Restraints
Table 15. Global Pharmaceutical CDMO Services Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Pharmaceutical CDMO Services Market Share by Players (2018-2023)
Table 17. Global Top Pharmaceutical CDMO Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical CDMO Services as of 2022)
Table 18. Ranking of Global Top Pharmaceutical CDMO Services Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Pharmaceutical CDMO Services Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Pharmaceutical CDMO Services Product Solution and Service
Table 22. Date of Enter into Pharmaceutical CDMO Services Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Pharmaceutical CDMO Services Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Pharmaceutical CDMO Services Revenue Market Share by Type (2018-2023)
Table 26. Global Pharmaceutical CDMO Services Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global Pharmaceutical CDMO Services Revenue Market Share by Type (2024-2033)
Table 28. Global Pharmaceutical CDMO Services Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Pharmaceutical CDMO Services Revenue Market Share by Application (2018-2023)
Table 30. Global Pharmaceutical CDMO Services Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global Pharmaceutical CDMO Services Revenue Market Share by Application (2024-2033)
Table 32. North America Pharmaceutical CDMO Services Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 33. North America Pharmaceutical CDMO Services Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Pharmaceutical CDMO Services Market Size by Country (2024-2033) & (US$ Million)
Table 35. Europe Pharmaceutical CDMO Services Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. Europe Pharmaceutical CDMO Services Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Pharmaceutical CDMO Services Market Size by Country (2024-2033) & (US$ Million)
Table 38. Asia-Pacific Pharmaceutical CDMO Services Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 39. Asia-Pacific Pharmaceutical CDMO Services Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Pharmaceutical CDMO Services Market Size by Region (2024-2033) & (US$ Million)
Table 41. Latin America Pharmaceutical CDMO Services Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 42. Latin America Pharmaceutical CDMO Services Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Pharmaceutical CDMO Services Market Size by Country (2024-2033) & (US$ Million)
Table 44. Middle East & Africa Pharmaceutical CDMO Services Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Middle East & Africa Pharmaceutical CDMO Services Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Pharmaceutical CDMO Services Market Size by Country (2024-2033) & (US$ Million)
Table 47. Recipharm AB Company Detail
Table 48. Recipharm AB Business Overview
Table 49. Recipharm AB Pharmaceutical CDMO Services Product
Table 50. Recipharm AB Revenue in Pharmaceutical CDMO Services Business (2018-2023) & (US$ Million)
Table 51. Recipharm AB Recent Development
Table 52. AMRI Global Company Detail
Table 53. AMRI Global Business Overview
Table 54. AMRI Global Pharmaceutical CDMO Services Product
Table 55. AMRI Global Revenue in Pharmaceutical CDMO Services Business (2018-2023) & (US$ Million)
Table 56. AMRI Global Recent Development
Table 57. Patheon N.V. Company Detail
Table 58. Patheon N.V. Business Overview
Table 59. Patheon N.V. Pharmaceutical CDMO Services Product
Table 60. Patheon N.V. Revenue in Pharmaceutical CDMO Services Business (2018-2023) & (US$ Million)
Table 61. Patheon N.V. Recent Development
Table 62. Aenova Group Company Detail
Table 63. Aenova Group Business Overview
Table 64. Aenova Group Pharmaceutical CDMO Services Product
Table 65. Aenova Group Revenue in Pharmaceutical CDMO Services Business (2018-2023) & (US$ Million)
Table 66. Aenova Group Recent Development
Table 67. Catalent, Inc. Company Detail
Table 68. Catalent, Inc. Business Overview
Table 69. Catalent, Inc. Pharmaceutical CDMO Services Product
Table 70. Catalent, Inc. Revenue in Pharmaceutical CDMO Services Business (2018-2023) & (US$ Million)
Table 71. Catalent, Inc. Recent Development
Table 72. Amatsigroup Company Detail
Table 73. Amatsigroup Business Overview
Table 74. Amatsigroup Pharmaceutical CDMO Services Product
Table 75. Amatsigroup Revenue in Pharmaceutical CDMO Services Business (2018-2023) & (US$ Million)
Table 76. Amatsigroup Recent Development
Table 77. WuXi AppTec Group Company Detail
Table 78. WuXi AppTec Group Business Overview
Table 79. WuXi AppTec Group Pharmaceutical CDMO Services Product
Table 80. WuXi AppTec Group Revenue in Pharmaceutical CDMO Services Business (2018-2023) & (US$ Million)
Table 81. WuXi AppTec Group Recent Development
Table 82. Strides Pharma Science Limited Company Detail
Table 83. Strides Pharma Science Limited Business Overview
Table 84. Strides Pharma Science Limited Pharmaceutical CDMO Services Product
Table 85. Strides Pharma Science Limited Revenue in Pharmaceutical CDMO Services Business (2018-2023) & (US$ Million)
Table 86. Strides Pharma Science Limited Recent Development
Table 87. Piramal Pharma Solutions Company Detail
Table 88. Piramal Pharma Solutions Business Overview
Table 89. Piramal Pharma Solutions Pharmaceutical CDMO Services Product
Table 90. Piramal Pharma Solutions Revenue in Pharmaceutical CDMO Services Business (2018-2023) & (US$ Million)
Table 91. Piramal Pharma Solutions Recent Development
Table 92. Siegfried Ltd Company Detail
Table 93. Siegfried Ltd Business Overview
Table 94. Siegfried Ltd Pharmaceutical CDMO Services Product
Table 95. Siegfried Ltd Revenue in Pharmaceutical CDMO Services Business (2018-2023) & (US$ Million)
Table 96. Siegfried Ltd Recent Development
Table 97. Fareva Group Company Detail
Table 98. Fareva Group Business Overview
Table 99. Fareva Group Pharmaceutical CDMO Services Product
Table 100. Fareva Group Revenue in Pharmaceutical CDMO Services Business (2018-2023) & (US$ Million)
Table 101. Fareva Group Recent Development
Table 102. FAMAR Health Care Services Company Detail
Table 103. FAMAR Health Care Services Business Overview
Table 104. FAMAR Health Care Services Pharmaceutical CDMO Services Product
Table 105. FAMAR Health Care Services Revenue in Pharmaceutical CDMO Services Business (2018-2023) & (US$ Million)
Table 106. FAMAR Health Care Services Recent Development
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pharmaceutical CDMO Services Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Pharmaceutical CDMO Services Market Share by Type: 2022 VS 2033
Figure 3. Drug Substance Development and Manufacturing Features
Figure 4. Specialized Services Features
Figure 5. Lab-based Services Features
Figure 6. Global Pharmaceutical CDMO Services Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 7. Global Pharmaceutical CDMO Services Market Share by Application: 2022 VS 2033
Figure 8. Innovative Medicine Case Studies
Figure 9. Patented Drug Case Studies
Figure 10. Patent Expired Drug Case Studies
Figure 11. Pharmaceutical CDMO Services Report Years Considered
Figure 12. Global Pharmaceutical CDMO Services Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global Pharmaceutical CDMO Services Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global Pharmaceutical CDMO Services Market Share by Region: 2022 VS 2033
Figure 15. Global Pharmaceutical CDMO Services Market Share by Players in 2022
Figure 16. Global Top Pharmaceutical CDMO Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical CDMO Services as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Pharmaceutical CDMO Services Revenue in 2022
Figure 18. North America Pharmaceutical CDMO Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America Pharmaceutical CDMO Services Market Share by Country (2018-2033)
Figure 20. United States Pharmaceutical CDMO Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Canada Pharmaceutical CDMO Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Pharmaceutical CDMO Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Pharmaceutical CDMO Services Market Share by Country (2018-2033)
Figure 24. Germany Pharmaceutical CDMO Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. France Pharmaceutical CDMO Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. U.K. Pharmaceutical CDMO Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Italy Pharmaceutical CDMO Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Russia Pharmaceutical CDMO Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Nordic Countries Pharmaceutical CDMO Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Pharmaceutical CDMO Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Pharmaceutical CDMO Services Market Share by Region (2018-2033)
Figure 32. China Pharmaceutical CDMO Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Japan Pharmaceutical CDMO Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. South Korea Pharmaceutical CDMO Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Southeast Asia Pharmaceutical CDMO Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. India Pharmaceutical CDMO Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Australia Pharmaceutical CDMO Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Pharmaceutical CDMO Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Pharmaceutical CDMO Services Market Share by Country (2018-2033)
Figure 40. Mexico Pharmaceutical CDMO Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Brazil Pharmaceutical CDMO Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Pharmaceutical CDMO Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Pharmaceutical CDMO Services Market Share by Country (2018-2033)
Figure 44. Turkey Pharmaceutical CDMO Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Saudi Arabia Pharmaceutical CDMO Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Recipharm AB Revenue Growth Rate in Pharmaceutical CDMO Services Business (2018-2023)
Figure 47. AMRI Global Revenue Growth Rate in Pharmaceutical CDMO Services Business (2018-2023)
Figure 48. Patheon N.V. Revenue Growth Rate in Pharmaceutical CDMO Services Business (2018-2023)
Figure 49. Aenova Group Revenue Growth Rate in Pharmaceutical CDMO Services Business (2018-2023)
Figure 50. Catalent, Inc. Revenue Growth Rate in Pharmaceutical CDMO Services Business (2018-2023)
Figure 51. Amatsigroup Revenue Growth Rate in Pharmaceutical CDMO Services Business (2018-2023)
Figure 52. WuXi AppTec Group Revenue Growth Rate in Pharmaceutical CDMO Services Business (2018-2023)
Figure 53. Strides Pharma Science Limited Revenue Growth Rate in Pharmaceutical CDMO Services Business (2018-2023)
Figure 54. Piramal Pharma Solutions Revenue Growth Rate in Pharmaceutical CDMO Services Business (2018-2023)
Figure 55. Siegfried Ltd Revenue Growth Rate in Pharmaceutical CDMO Services Business (2018-2023)
Figure 56. Fareva Group Revenue Growth Rate in Pharmaceutical CDMO Services Business (2018-2023)
Figure 57. FAMAR Health Care Services Revenue Growth Rate in Pharmaceutical CDMO Services Business (2018-2023)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed